You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myasthenia Gravis

Showing 1 - 25 of 407
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myasthenia Gravis and Psyche

Completed
  • Myasthenia Gravis
    • Berlin, Germany
      NeuroCure Clinical Research Center (NCRC), Charité
    Jan 6, 2023

    Myasthenia Gravis Trial in New Haven (Blood Sample Draw)

    Recruiting
    • Myasthenia Gravis
    • Blood Sample Draw
    • New Haven, Connecticut
      Yale-New Haven Hospital
    Nov 14, 2022

    Myasthenia Gravis, Generalized Trial in Roma (Rituximab, Placebo)

    Recruiting
    • Myasthenia Gravis, Generalized
    • Roma, Italy
      Policlinico A. Gemelli IRCCS
    May 25, 2023

    Myasthenia Gravis Trial in Guangzhou (Body fluid diagnosis)

    Enrolling by invitation
    • Myasthenia Gravis
    • Body fluid diagnosis
    • Guangzhou, Guangdong, China
      First Affiliated Hospital of Jinan University
    May 25, 2023

    Generalized Myasthenia Gravis Trial (Rozanolixizumab)

    Not yet recruiting
    • Generalized Myasthenia Gravis
    • (no location specified)
    Jan 4, 2023

    Myasthenia Gravis Trial (ME&MG mobile application)

    Not yet recruiting
    • Myasthenia Gravis
    • ME&MG mobile application
    • (no location specified)
    Jan 12, 2023

    Myasthenia Gravis Trial in Saint Paul (Acupuncture)

    Recruiting
    • Myasthenia Gravis
    • Acupuncture
    • Saint Paul, Minnesota
      HealthPartners Neuroscience Center
    Jul 27, 2022

    Myasthenia Gravis Trial in Toronto (subcutaneous immunoglobulin (SCIG), intravenous immunoglobulin + subcutaneous immunoglobulin

    Recruiting
    • Myasthenia Gravis
    • subcutaneous immunoglobulin (SCIG)
    • intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG)
    • Toronto, Ontario, Canada
      University Health Network
    Nov 21, 2022

    Myasthenia Gravis Trial in Hangzhou (CD19 CAR-T cells injection)

    Recruiting
    • Myasthenia Gravis
    • CD19 CAR-T cells injection
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Apr 12, 2023

    Predictors and Prognostic Factors of Myasthenia Gravis Outcome

    Recruiting
    • Myasthenia Gravis
    • +11 more
    • Drug treatment of myasthenia gravis and treatment of crisis
    • Assiut, Egypt
      Assiut University
    Feb 22, 2022

    Exercise in Autoimmune Myasthenia Gravis and Myasthenic

    Completed
    • Autoimmune Myasthenia Gravis
    • +3 more
      • Paris, France
        Online Questionnaire
      Jun 3, 2022

      Interleukin and Autoantibodies in Myasthenia Gravis.

      Not yet recruiting
      • Myasthenia Gravis
      • real time PCR , ELISA
      • (no location specified)
      Apr 27, 2022

      MuSK Myasthenia Gravis Trial (MuSK-CAART)

      Not yet recruiting
      • MuSK Myasthenia Gravis
      • MuSK-CAART
      • (no location specified)
      Jul 5, 2022

      Ocular Myasthenia Gravis Trial in Xi'an (Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus,

      Recruiting
      • Ocular Myasthenia Gravis
      • Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil)
      • Xi'an, Shaanxi, China
        Tangdu Hospotal
      Aug 16, 2022

      s of Sugammadex on Postoperative Progress in Myasthenia Gravis

      Completed
      • Myasthenia Gravis
        • Seoul, Korea, Republic of
          Yonsei University Health System, Severance Hospital
        Jan 20, 2023

        The Specificity, Sensitivity and Clinical Correlation of CBA,

        Completed
        • Detection Autoantibody of Myasthenia Gravis
        • CBA Assay
        • Beijing, China
        • +1 more
        Jan 17, 2023

        Generalized Myasthenia Gravis Trial (zilucoplan (RA101495))

        Not yet recruiting
        • Generalized Myasthenia Gravis
        • zilucoplan (RA101495)
        • (no location specified)
        Aug 22, 2022

        Sensitivity of Repetitive Nerve Stimulation Performed in Evening

        Recruiting
        • Myasthenia Gravis
          • Kraków, Lesser Poland, Poland
            Jagiellonian University Medical College, Department of Neurology
          Aug 13, 2022

          Generalized Myasthenia Gravis, gMG Trial (Ravulizumab)

          Not yet recruiting
          • Generalized Myasthenia Gravis
          • gMG
          • (no location specified)
          Dec 1, 2022

          Myasthenia Gravis, Generalized Trial in China (Tocilizumab Injection)

          Enrolling by invitation
          • Myasthenia Gravis, Generalized
          • Tocilizumab Injection
          • Beijing, Beijing, China
          • +5 more
          Jan 27, 2023

          Generalized Myasthenia Gravis Trial (Efgartigimod IV)

          Recruiting
          • Generalized Myasthenia Gravis
          • Efgartigimod IV
          • Leiden, Netherlands
          • +2 more
          Jan 16, 2023

          Myasthenia Gravis Trial in GuangZhou (Azathioprine, Leflunomide)

          Completed
          • Myasthenia Gravis
          • Guangzhou, Guangdong, China
            The First Affiliated Hospital, SUN YAT-SEN UNIVERSITY
          Apr 6, 2022

          Myasthenia Gravis, MuSK Trial in Cleveland, Philadelphia (Amifampridine Phosphate)

          Active, not recruiting
          • Myasthenia Gravis, MuSK
          • Amifampridine Phosphate
          • Cleveland, Ohio
          • +1 more
          Jul 21, 2022

          Refractory Myasthenia Gravis, Rituximab Trial in Guangzhou (Rituximab)

          Recruiting
          • Refractory Myasthenia Gravis
          • Rituximab
          • Guangzhou, China
            First Affiliated Hospital, Sun Yat-Sen University
          Apr 26, 2022

          Burden of Disease in Myasthenia Gravis

          Completed
          • Myasthenia Gravis
            • Berlin-Mitte, Germany
              NeuroCure Clinical Research Center (NCRC), Charité University, B
            Dec 15, 2021